New drug aimed at stopping breast cancer return after surgery
Disease control
Ongoing
This early-phase trial tests a new drug called SRG-514, which is applied directly to the area where breast cancer is removed during surgery. The goal is to find the safest dose and see how the body handles it. About 24 adults with breast cancer who are having breast-conserving su…
Phase: PHASE1 • Sponsor: SURGE Therapeutics • Aim: Disease control
Last updated May 02, 2026 04:43 UTC